GlaxoSmithKline cancer drug threatens Herceptin market


	Journal home

	Advance online publication

	Current issue

	Archive

	Press releases



	Supplements

	Focuses

	Conferences

Guide to authors


	NPG Resources

	Bioentrepreneur

	Nature Reviews Drug Discovery

	Nature

	Nature Medicine

	Nature Genetics

	Nature Reviews Genetics

	Nature Methods

	Nature Chemical Biology

	news@nature.com

	Clinical Pharmacology & Therapeutics

	Nature Conferences

Molecular Cell Biology

Neuroscience

Pharmacology

Physics

Browse all publications

News

Nature Biotechnology 23, 1453 - 1454 (2005)
Published online: 6 December 2005; | doi:10.1038/nbt1205-1453

GlaxoSmithKline cancer drug threatens Herceptin market

Emily Waltz

New York

The first targeted therapy for breast cancer could soon face direct competition.

	Top

Abstract

| Next

Table of contents


	Full text

	Download PDF

	Send to a friend

	Rights and permissions
	Order commercial reprints

	Save this link

nature jobs

Associate Professor / Assistant Professor in Plant Molecular Biolog
- Hong Kong Baptist University
- Hong Kong, China 852 China
PhD Scholarships
- University of Glasgow / British Heart Foundation
- Glasgow, Scotland

More science jobs

Post a job for free


	Figures & Tables


	Export citation






	Search buyers guide:


ISSN: 1087-0156 EISSN: 1546-1696	Journal home \| Advance online publication \| Current issue \| Archive \| Press releases \| Supplements \| Focuses \| Conferences \| For authors \| Online submission \| Permissions \| For referees \| Free online issue \| About the journal \| Contact the journal \| Subscribe \| Advertising \| work@npg \| naturereprints \| About this site \| For librarians


		©2005 Nature Publishing Group \| Privacy policy

GlaxoSmithKline cancer drug threatens Herceptin market

nature jobs

Associate Professor / Assistant Professor in Plant Molecular Biolog

PhD Scholarships